Phase II study of Kynurenic acid (FS2) prevention of post-surgical scar formation
Phase of Trial: Phase II
Latest Information Update: 21 Feb 2018
At a glance
- Drugs Kynurenic acid (Primary)
- Indications Scars
- Focus Adverse reactions; Therapeutic Use
- 21 Feb 2018 New trial record
- 16 Feb 2018 According to a BirchBioMed media release, the company got clearance by Health Canada to begin a phase II clinical trial of FS2.
- 16 Feb 2018 Dr. Anthony Papp, M.D. Ph.D will be principal investigator for this study.